37
Janus Henderson Biotech Innovation Fund II Ltd updates its Form D — $402M sold
Fund raise update · Other fund · Open-ended · Grand Cayman, Cayman Islands · Form D/A filed 2025-08-18 · all Janus Henderson Biotech vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| Matteo Candolfini | Director |
| N/A Janus Henderson Investors US LLC | Investment Manager of the Issuer |
| Kenneth M.B. Lubbock | Director |
| Hugh Ward | Director |
| Toby Hiscock | Director |
Signed by Steven Schneider, Legal Counsel.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.